Literature DB >> 1526884

Permeability changes of the blood-labyrinth barrier measured in vivo during experimental treatments.

N Inamura1, A N Salt.   

Abstract

The communication between blood and cochlear perilymph was investigated using the tracer ion trimethylphenylammonium (TMPA). TMPA can be detected in micromolar concentrations by ion-selective microelectrodes, allowing it to be used as an almost ideal marker to study intercommunication between fluid compartments. TMPA-sensitive electrodes were sealed into the cochlear scalae, using procedures which avoided the artifactual displacement of perilymph by cerebrospinal fluid (CSF). TMPA was infused intravenously at a low rate to produce a plasma concentration of approximately 0.5, mM. The time course of entry into perilymph of scala tympani (ST), scala vestibuli (SV) and into CSF were compared. After 90 min infusion, the mean CSF concentration reached 14.3% of that measured in plasma. The TMPA concentrations measured in ST and SV perilymph were significantly lower than those recorded in CSF, only reaching an average of 6.5% and 3.7% of the plasma concentration respectively after 90 min. The slow entry of TMPA confirms the existence of a tight blood-labyrinth barrier, equivalent to the blood-brain or blood-CSF barriers. The rate of TMPA entry into perilymph was increased by epinephrine-induced hypertension or by simultaneous administration of histamine and prostaglandin E2. These treatments are presumed to increase the permeability of the blood-labyrinth barrier. Characterization and manipulation of blood-labyrinth barrier permeability could be important to our understanding cochlear pathology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526884     DOI: 10.1016/0378-5955(92)90030-q

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  19 in total

1.  Pharmacokinetics of Drug Entry into Cochlear Fluids.

Authors:  Alec N Salt
Journal:  Volta Rev       Date:  2005

2.  Development of a microfluidics-based intracochlear drug delivery device.

Authors:  William F Sewell; Jeffrey T Borenstein; Zhiqiang Chen; Jason Fiering; Ophir Handzel; Maria Holmboe; Ernest S Kim; Sharon G Kujawa; Michael J McKenna; Mark M Mescher; Brian Murphy; Erin E Leary Swan; Marcello Peppi; Sarah Tao
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

3.  Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.

Authors:  Keiko Hirose; Jared J Hartsock; Shane Johnson; Peter Santi; Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2014-06-21

Review 4.  Communication pathways to and from the inner ear and their contributions to drug delivery.

Authors:  Alec N Salt; Keiko Hirose
Journal:  Hear Res       Date:  2017-12-19       Impact factor: 3.208

5.  Inner ear drug delivery via a reciprocating perfusion system in the guinea pig.

Authors:  Zhiqiang Chen; Sharon G Kujawa; Michael J McKenna; Jason O Fiering; Mark J Mescher; Jeffrey T Borenstein; Erin E Leary Swan; William F Sewell
Journal:  J Control Release       Date:  2005-11-07       Impact factor: 9.776

Review 6.  Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.

Authors:  Sophie Nyberg; N Joan Abbott; Xiaorui Shi; Peter S Steyger; Alain Dabdoub
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

7.  Infection-mediated vasoactive peptides modulate cochlear uptake of fluorescent gentamicin.

Authors:  Ja-Won Koo; Qi Wang; Peter S Steyger
Journal:  Audiol Neurootol       Date:  2010-12-30       Impact factor: 1.854

8.  Local drug delivery with a self-contained, programmable, microfluidic system.

Authors:  J Fiering; M J Mescher; E E Leary Swan; M E Holmboe; B A Murphy; Z Chen; M Peppi; W F Sewell; M J McKenna; S G Kujawa; J T Borenstein
Journal:  Biomed Microdevices       Date:  2009-06       Impact factor: 2.838

9.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

10.  Geldanamycin induces production of heat shock protein 70 and partially attenuates ototoxicity caused by gentamicin in the organ of Corti explants.

Authors:  Yang Yu; Agnieszka J Szczepek; Heidemarie Haupt; Birgit Mazurek
Journal:  J Biomed Sci       Date:  2009-09-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.